Clinical Trial Update: Flecainide Safety in Patients With Coronary Artery Disease and Atrial Fibrillation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the safety of flecainide in patients with atrial fibrillation and coronary artery disease, with recruitment not yet start…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Coronary Artery Disease

Drugs mentioned

• flecainide (flecainide)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Atrial Fibrillation (AF), Coronary Artery Disease | Phase 4 | Status: NOT_YET_RECRUITING